Cargando…

Obviation of dyslipidemia by garlic oil and its organosulfur compound, diallyl disulphide, in experimental animals

BACKGROUND AND OBJECTIVES: Garlic and its number of preparations are known to be effective for treatment of dyslipidemia, but the data about the specific active constituents of the garlic on the possible therapeutic value is scarce. Therefore, the aim of this research was to evaluate the role of gar...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed Basheeruddin Asdaq, Syed, Yasmin, Farhana, Alsalman, Abdulkhaliq J., Al mohaini, Mohammed, Kamal, Mehnaz, Al Hawaj, Maitham A., Alsalman, Khaled J., Imran, Mohd., Sreeharsha, Nagaraja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072925/
https://www.ncbi.nlm.nih.gov/pubmed/35531198
http://dx.doi.org/10.1016/j.sjbs.2021.12.025
_version_ 1784701170408751104
author Mohammed Basheeruddin Asdaq, Syed
Yasmin, Farhana
Alsalman, Abdulkhaliq J.
Al mohaini, Mohammed
Kamal, Mehnaz
Al Hawaj, Maitham A.
Alsalman, Khaled J.
Imran, Mohd.
Sreeharsha, Nagaraja
author_facet Mohammed Basheeruddin Asdaq, Syed
Yasmin, Farhana
Alsalman, Abdulkhaliq J.
Al mohaini, Mohammed
Kamal, Mehnaz
Al Hawaj, Maitham A.
Alsalman, Khaled J.
Imran, Mohd.
Sreeharsha, Nagaraja
author_sort Mohammed Basheeruddin Asdaq, Syed
collection PubMed
description BACKGROUND AND OBJECTIVES: Garlic and its number of preparations are known to be effective for treatment of dyslipidemia, but the data about the specific active constituents of the garlic on the possible therapeutic value is scarce. Therefore, the aim of this research was to evaluate the role of garlic oil (GO) and its active element, diallyl disulphide (DADS) for obviating dyslipidemia in animal model. METHODS: High fat diet (HFD) was given to animals to induce dyslipidemia. Animals of HFD groups were fed with atherogenic diet for 15 days prior to treatment. Animals in their respective groups received vehicle, GO (50 and 100 mg/kg), and DADS (4.47 and 8.94 mg/kg) for five consecutive days. Lipid profiles were estimated in serum, oxidant/antioxidant and liver profile were measured in liver tissue homogenate (LTH). RESULTS: Animals fed on HFD developed significant increase in the serum levels of triglycerides (TG), total cholesterol (TC), lactate dehydrogenase (LDL), malondialdehyde (MDA), glutathione peroxidase (GSHPx), glutathione (GSH), and glutathione disulfide (GSSG) that reduced significantly in groups that received GO and DADS treatments. Additionally, significant elevation in serum high density lipoprotein (HDL) level was observed in animals that received GO and DADS. Moreover, hepatic markers such as alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine transferase (ALT), that were abnormally altered by high fat diet, were significantly restored to almost normal values with GO and DADS treatments. Also, antioxidants such as superoxide dismutase (SOD), catalase (CAT), ferric reducing antioxidant power (FRAP), and total thiol (SH) levels in LTH were increased significantly in GO and DADS treated groups. When compared to DADS, GO showed better therapeutic effectiveness in terms of antihyperlipidemic and antioxidant properties. CONCLUSION: In hyperlipidemic rats, garlic and its principal active component, diallyl disulphide, were effective in avoiding dyslipidemia and neutralizing reactive free radicals induced by a high fat diet. It's an intriguing observation that GO has a larger therapeutic influence than its active constituent, DADS. These findings suggest that other constituents, in addition to GO's DADS, are involved in the compound's synergistic antihyperlipidemic and antioxidant activities.
format Online
Article
Text
id pubmed-9072925
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90729252022-05-07 Obviation of dyslipidemia by garlic oil and its organosulfur compound, diallyl disulphide, in experimental animals Mohammed Basheeruddin Asdaq, Syed Yasmin, Farhana Alsalman, Abdulkhaliq J. Al mohaini, Mohammed Kamal, Mehnaz Al Hawaj, Maitham A. Alsalman, Khaled J. Imran, Mohd. Sreeharsha, Nagaraja Saudi J Biol Sci Original Article BACKGROUND AND OBJECTIVES: Garlic and its number of preparations are known to be effective for treatment of dyslipidemia, but the data about the specific active constituents of the garlic on the possible therapeutic value is scarce. Therefore, the aim of this research was to evaluate the role of garlic oil (GO) and its active element, diallyl disulphide (DADS) for obviating dyslipidemia in animal model. METHODS: High fat diet (HFD) was given to animals to induce dyslipidemia. Animals of HFD groups were fed with atherogenic diet for 15 days prior to treatment. Animals in their respective groups received vehicle, GO (50 and 100 mg/kg), and DADS (4.47 and 8.94 mg/kg) for five consecutive days. Lipid profiles were estimated in serum, oxidant/antioxidant and liver profile were measured in liver tissue homogenate (LTH). RESULTS: Animals fed on HFD developed significant increase in the serum levels of triglycerides (TG), total cholesterol (TC), lactate dehydrogenase (LDL), malondialdehyde (MDA), glutathione peroxidase (GSHPx), glutathione (GSH), and glutathione disulfide (GSSG) that reduced significantly in groups that received GO and DADS treatments. Additionally, significant elevation in serum high density lipoprotein (HDL) level was observed in animals that received GO and DADS. Moreover, hepatic markers such as alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine transferase (ALT), that were abnormally altered by high fat diet, were significantly restored to almost normal values with GO and DADS treatments. Also, antioxidants such as superoxide dismutase (SOD), catalase (CAT), ferric reducing antioxidant power (FRAP), and total thiol (SH) levels in LTH were increased significantly in GO and DADS treated groups. When compared to DADS, GO showed better therapeutic effectiveness in terms of antihyperlipidemic and antioxidant properties. CONCLUSION: In hyperlipidemic rats, garlic and its principal active component, diallyl disulphide, were effective in avoiding dyslipidemia and neutralizing reactive free radicals induced by a high fat diet. It's an intriguing observation that GO has a larger therapeutic influence than its active constituent, DADS. These findings suggest that other constituents, in addition to GO's DADS, are involved in the compound's synergistic antihyperlipidemic and antioxidant activities. Elsevier 2022-04 2021-12-20 /pmc/articles/PMC9072925/ /pubmed/35531198 http://dx.doi.org/10.1016/j.sjbs.2021.12.025 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Mohammed Basheeruddin Asdaq, Syed
Yasmin, Farhana
Alsalman, Abdulkhaliq J.
Al mohaini, Mohammed
Kamal, Mehnaz
Al Hawaj, Maitham A.
Alsalman, Khaled J.
Imran, Mohd.
Sreeharsha, Nagaraja
Obviation of dyslipidemia by garlic oil and its organosulfur compound, diallyl disulphide, in experimental animals
title Obviation of dyslipidemia by garlic oil and its organosulfur compound, diallyl disulphide, in experimental animals
title_full Obviation of dyslipidemia by garlic oil and its organosulfur compound, diallyl disulphide, in experimental animals
title_fullStr Obviation of dyslipidemia by garlic oil and its organosulfur compound, diallyl disulphide, in experimental animals
title_full_unstemmed Obviation of dyslipidemia by garlic oil and its organosulfur compound, diallyl disulphide, in experimental animals
title_short Obviation of dyslipidemia by garlic oil and its organosulfur compound, diallyl disulphide, in experimental animals
title_sort obviation of dyslipidemia by garlic oil and its organosulfur compound, diallyl disulphide, in experimental animals
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072925/
https://www.ncbi.nlm.nih.gov/pubmed/35531198
http://dx.doi.org/10.1016/j.sjbs.2021.12.025
work_keys_str_mv AT mohammedbasheeruddinasdaqsyed obviationofdyslipidemiabygarlicoilanditsorganosulfurcompounddiallyldisulphideinexperimentalanimals
AT yasminfarhana obviationofdyslipidemiabygarlicoilanditsorganosulfurcompounddiallyldisulphideinexperimentalanimals
AT alsalmanabdulkhaliqj obviationofdyslipidemiabygarlicoilanditsorganosulfurcompounddiallyldisulphideinexperimentalanimals
AT almohainimohammed obviationofdyslipidemiabygarlicoilanditsorganosulfurcompounddiallyldisulphideinexperimentalanimals
AT kamalmehnaz obviationofdyslipidemiabygarlicoilanditsorganosulfurcompounddiallyldisulphideinexperimentalanimals
AT alhawajmaithama obviationofdyslipidemiabygarlicoilanditsorganosulfurcompounddiallyldisulphideinexperimentalanimals
AT alsalmankhaledj obviationofdyslipidemiabygarlicoilanditsorganosulfurcompounddiallyldisulphideinexperimentalanimals
AT imranmohd obviationofdyslipidemiabygarlicoilanditsorganosulfurcompounddiallyldisulphideinexperimentalanimals
AT sreeharshanagaraja obviationofdyslipidemiabygarlicoilanditsorganosulfurcompounddiallyldisulphideinexperimentalanimals